What is Vedolizumab?

Category: Prescription Drugs

Most popular types: Entyvio

false

Vedolizumab is an injectable product that may be used for the treatment of moderately to severely active ulcerative colitis and Crohn's disease.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
6
Mild
5
None
6

Commonly reported side effects and conditions associated with Vedolizumab

Side effect Patients
Joint pain 2
Anxious mood 1
Cough 1
Diarrhea 1
Fatigue 1
Hair loss 1

Show all 13 reported side effects

Dosages

Based on patients currently taking Vedolizumab

Dosage Patients
300 mg every 8 weeks 5
300 mg monthly 2
every 8 weeks 1

Why patients stopped taking Vedolizumab

Multiple reasons could be selected

Reason Patients
Did not seem to work 2
Doctor's advice 1
Other 1
Side effects too severe 1
See all 3 patients who've stopped taking Vedolizumab

Duration

Currently taking Vedolizumab

Duration Patients
6 months - 1 year 3
1 - 2 years 3
2 - 5 years 2

Stopped taking Vedolizumab

Duration Patients
1 - 6 months 1
6 months - 1 year 1
1 - 2 years 1
Adherence
Adherence Evaluations
Always 15
Usually 1
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 3
A little hard to take 3
Not at all hard to take 11
Cost per month
Cost per month Evaluations
$200+ 2
$100-199 0
$50-99 2
$25-49 2
< $25 5
Not specified 6

What people switch to and from

Patients started taking Vedolizumab after stopping:

Treatment Patients
Adalimumab (Humira) 8
Infliximab (Remicade) 4
Certolizumab (Cimzia) 2
Budesonide (Pulmicort) 1
Golimumab (Simponi SmartJect) 1

Show all 7 treatments patients report switching from

Patients stopped taking Vedolizumab and switched to:

Treatment Patients
Infliximab-dyyb (Inflectra) 1
Last updated:
There are no evaluations for Vedolizumab.